Home / Drug shortages / Riboflavin 5-phosphate Ophthalmic Solution

Riboflavin 5-phosphate Ophthalmic Solution — FDA Drug Shortage

To Be Discontinued — Glaukos Corporation

The FDA lists a drug shortage record for Riboflavin 5-phosphate Ophthalmic Solution (ophthalmic solution) from Glaukos Corporation with status To Be Discontinued. The shortage was first posted on 01/20/2026.

Shortage Details

Status
To Be Discontinued
Company
Glaukos Corporation
Package NDC
25357-025-03
Dosage Form
Ophthalmic Solution
Presentation
Photrexa Cross-linking Kit, Ophthalmic Solution, Kit (NDC 25357-025-03)
Initial Posting
01/20/2026
Revised Date

FDA data resources